Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

Mutations within FGFR1 are associated with superior outcome in a series of 83 diffuse midline gliomas with H3F3A K27M mutations

(2021) Ulrich Schüller et al.   ACTA NEUROPATHOLOGICA

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

(2021) David N Louis et al.   NEURO-ONCOLOGY

Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas

(2020) Scott Ryall et al.   CANCER CELL

Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas

(2018) Drew Pratt et al.   ACTA NEUROPATHOLOGICA

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

(2012) Dong-Anh Khuong-Quang et al.   ACTA NEUROPATHOLOGICA